Dendritic Vaccine for Glioblastoma: Hope Hyped, Say Some Dendritic Vaccine for Glioblastoma: Hope Hyped, Say Some

Survival for patients with newly diagnosed glioblastoma may be given a boost if initial results of dendritic vaccines using patients'own cells hold up. But experts are skeptical.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
CONCLUSION: The advantage of quadrivalent HPV vaccine in the treatment of warts is that it is more convenient and less painful. HPV vaccine might be a good alternative to conventional destructive methods for incompetent cases such as those including multiple warts, dangerous lesion locations, and uncooperative patients. PMID: 30232912 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
There’s a very big difference between simple and easy—especially when it comes to global health. It’s simple to eradicate polio—just get all children are vaccinated. It’s simple to reduce nighttime malaria infections—make sure everyone in malaria-endemic areas sleeps under a bed net. But none of that is easy. The tension between simple and easy is at play when it comes to eradicating poverty in the developing world too, as the Bill &Melinda Gates Foundation makes clear in its second annual Goalkeepers Data Report. In a conversation with TIME, Bill Gates points to two recent waves of ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized onetime public health Source Type: news
ConclusionsBetween 2005 and 2010, 27.8% and 8.14% of healthy children in southern Taiwan had nasal carriage of S. aureus and MRSA, respectively. Most MRSA isolates were local community strains. Several demographic factors associated with nasal MRSA colonization were identified.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news
Conditions:   Safety Issues;   Immunogenicity Intervention:   Biological: Measles-Rubella (MR) Vaccine Sponsors:   PT Bio Farma;   Child Health Dept. Dr. Soetomo Hospital/School of Medicine, Airlangga Univ. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 19 September 2018Source: Microbial PathogenesisAuthor(s): Hizbullah, Zarghoona Nazir, Sahib Gul Afridi, Mohibullah Shah, Sulaiman Shams, Asifullah KhanAbstractThe Burkholderia pseudomallei is a unique bio-threat and causative agent of melioidosis. The B. pseudomallei Bp1651 strain has been isolated from a chronic cystic fibrosis patient. The genome-level DNA sequences information of this strain has recently been published. Unfortunately, there is no commercial vaccine available till date to combat B. pseudomallei infection. The genome-wide prioritization approaches are widely used for the...
Source: Microbial Pathogenesis - Category: Infectious Diseases Source Type: research
An investigation published by The BMJ has questioned the transparency around the safety of GlaxoSmithKline's “Pandemrix” swine flu vaccine.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
Antibody half-life varies tremendously, from about 11 years for tetanus to over 200 years for measles and mumps.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Mumps Measles Tetanus Smallpox Viruses Vaccination and Immunization Diphtheria Infections Source Type: news
Scientists have found some surprising common ground between the Zika virus and brain cancer. They hope that a Zika vaccine may help combat glioblastoma.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
More News: Cancer & Oncology | Health | Hematology | Vaccines